ArticleInternational journal of molecular sciences2023

Preclinical Efficacy of a PARP-1 Targeted Auger-Emitting Radionuclide in Prostate Cancer.

Sreeja Sreekumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.